Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Agenus Inc
(NQ:
AGEN
)
13.57
+0.58 (+4.46%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
383,649
Open
12.95
Bid (Size)
13.27 (10)
Ask (Size)
13.65 (4)
Prev. Close
12.99
Today's Range
12.59 - 13.63
52wk Range
0.4100 - 19.69
Shares Outstanding
348,875,959
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Agenus Announces Appointment of Dr. Jennifer Buell to Its Board of Directors
June 17, 2024
From
Agenus Inc.
Via
Business Wire
Nature Medicine Reports Agenus’ Novel Immunotherapy Demonstrates Clinical Activity Against a Deadly Form of Colorectal Cancer on the Rise in Americans Under 50
June 13, 2024
From
Agenus
Via
Business Wire
Performance
YTD
+1595.83%
+1595.83%
1 Month
+22.03%
+22.03%
3 Month
+2313.73%
+2313.73%
6 Month
+1645.11%
+1645.11%
1 Year
+637.50%
+637.50%
More News
Read More
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 05, 2024
Via
Benzinga
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 04, 2024
Via
Benzinga
Saia, Annexon, Core Scientific And Other Big Stocks Moving Higher On Tuesday
June 04, 2024
Via
Benzinga
Agenus Announces Virtual Annual Shareholders Meeting
June 04, 2024
From
Agenus Inc.
Via
Business Wire
Medical Moonshots: 3 Biotech Stocks Set to Skyrocket
May 30, 2024
Via
InvestorPlace
7 Biotech Stocks to Put on Your Breakthrough Radar
May 27, 2024
Via
InvestorPlace
Up 40%: Is This Red-Hot Growth Stock Still a Buy?
April 28, 2024
Via
The Motley Fool
Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 24, 2024
From
Agenus Inc.
Via
Business Wire
Breakthrough Data on Botensilimab/Balstilimab in MSS CRC Presented at the 2024 ASCO Annual Meeting
May 23, 2024
From
Agenus Inc.
Via
Business Wire
Agenus to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
May 23, 2024
From
Agenus Inc.
Via
Business Wire
3 Magnificent Growth Stocks to Buy Hand Over Fist
May 22, 2024
Via
The Motley Fool
Topics
Economy
Exposures
Interest Rates
FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/BAL Therapy for Relapsed or Refractory Metastatic Colorectal Cancer
May 16, 2024
From
Agenus Inc.
Via
Business Wire
Agenus (AGEN) Q1 2024 Earnings Call Transcript
May 07, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
AGEN Stock Earnings: Agenus Misses EPS, Misses Revenue for Q1 2024
May 07, 2024
Via
InvestorPlace
Agenus Reports First Quarter 2024 Results
May 07, 2024
From
Agenus Inc.
Via
Business Wire
Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
May 07, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Agenus Regains Compliance with Nasdaq Minimum Bid Price Requirement
May 01, 2024
From
Agenus Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
April 26, 2024
Via
Benzinga
Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting
April 24, 2024
From
Agenus Inc.
Via
Business Wire
Top 2 Health Care Stocks Which Could Rescue Your Portfolio This Month
April 23, 2024
Via
Benzinga
Agenus to Provide First Quarter 2024 Financial Report and Corporate Update
April 23, 2024
From
Agenus Inc.
Via
Business Wire
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 12, 2024
Via
Benzinga
Small-Cap Cancer Drug Developer Agenus' Highlights Encouraging Data From Colorectal Cancer, But Funding Concerns Loom
April 12, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.